Programmed cell death protein 4 expression in renal cell carcinoma, penile carcinoma and testicular germ cell cancer

doi:10.5410/wjcu.v3.i3.351

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7881)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

360

WORD

225

HTML

2234

Figures (1-6)

243

Tables (1-4)

379

Sum=3441

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

680

Download

1393

Sum=2073

Publishing Process of This Article

Item

Count

Browse

1119

Download

1248

Sum=2367

Nov 24, 2014 (publication date) through Nov 6, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Urology

ISSN

2219-2816

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Clin Urol. Nov 24, 2014; 3(3): 351-357
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.351

Full Size Figure Download Figure

Figure 3 Percentual distribution of core intensity (A), cytoplasmatic-(B) and programmed cell death 4 staining results in correlation to renal cell carcinoma subtype and controls. Left weak/negative staining, right strong/positive staining result. RCC: Renal cell carcinoma; ccRCC: Clear cell RCC; pRCC: Papillary RCC; chRCC: Chromophobe RCC; sRCC: Sarcomatoid RCC.

Citation: Fischer N, Göke F, Kahl P, Splittstößer V, Lankat-Buttgereit B, Müller SC, Ellinger J. Programmed cell death protein 4 expression in renal cell carcinoma, penile carcinoma and testicular germ cell cancer. World J Clin Urol 2014; 3(3): 351-357
URL: https://www.wjgnet.com/2219-2816/full/v3/i3/351.htm
DOI: https://dx.doi.org/10.5410/wjcu.v3.i3.351